Abstract
Biochemistry plays a pivotal role in unraveling the molecular mechanisms of cancer, enabling early diagnosis, accurate prognosis, and the development of targeted therapies. From understanding oncogene expression and tumor metabolism to designing enzyme-inhibitor-based drugs, biochemical approaches provide deep insights into cancer pathophysiology. This article reviews recent advances in cancer biochemistry and their translation into therapeutic strategies. Furthermore, we examine the role of biomarkers, cell signaling cascades, and drug resistance mechanisms to demonstrate the utility of biochemistry in modern oncology.
All articles published in the Austra & Lian Journal of Basic Sciences are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors retain full copyright of their work, and readers are free to share, copy, redistribute, adapt, and build upon the material in any medium or format, provided appropriate credit is given to the original authors and source, a link to the license is provided, and any changes made are clearly indicated. This open-access license promotes the widest possible dissemination and use of research outputs.